Decoding DMD transcriptional networks using single‐nucleus RNA sequencing
- aDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455;
- bPaul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota, Minneapolis, MN 55455
See allHide authors and affiliations

Duchenne muscular dystrophy (DMD) is an X chromosome-linked disease, and it is the most common form of muscular dystrophy caused by genetic mutations in the Dmd gene (1). The Dmd gene contains 79 exons, spans 2.4 Mb, and is the single largest gene in the human genome (2). This gene encodes for dystrophin, which is a component of the dystrophin–glycoprotein complex that provides structural stability to the cell membrane (by connecting the cytoskeleton and the extracellular matrix), and a dysfunctional or absent dystrophin protein leads to progressive muscle wasting with cycles of muscle degeneration and regeneration that ultimately fail (3, 4). Young boys with DMD lose their ability to ambulate, become wheelchair bound, and die prematurely (1, 5). This disease affects skeletal muscle, which is the single largest organ in the body, and it normally has a remarkable capacity for regeneration (6). In response to a severe injury caused by genetic disorders, trauma, or exposure to toxins that destroys over 90% of the muscle, the cytoarchitecture of the injured tissue is completely restored and is indistinguishable compared to uninjured muscle within a 2- to 4-wk period. This regenerative capacity is due to the myogenic stem cell population (i.e., satellite cells) that is resident in adult skeletal muscle, and with repeated DMD-mediated degeneration and regeneration this regenerative process ultimately is exhausted (6). While a number of studies have enhanced our understanding of the myogenic stem cell population, new insights are needed regarding the factors that govern muscle regeneration and potentially serve as therapies for diseases like DMD. In PNAS, Chemello et al. (7) use emerging technologies to provide a discovery science platform. First, they engineered a mouse model by deleting exon 51 of the Dmd gene. This gene-edited mouse (ΔEx51) was viable, lacked dystrophin in skeletal muscle and heart, …
↵1To whom correspondence may be addressed. Email: garry{at}umn.edu.
References
- ↵
- F. Kamdar,
- D. J. Garry
- ↵
- ↵
- I. N. Rybakova,
- J. R. Patel,
- J. M. Ervasti
- ↵
- D. E. Michele,
- K. P. Campbell
- ↵
- F. Kamdar et al
- ↵
- X. Shi,
- D. J. Garry
- ↵
- F. Chemello, et al
- ↵
- G. Bulfield,
- W. G. Siller,
- P. A. Wight,
- K. J. Moore
- ↵
- ↵
- ↵
- ↵
- C. Long et al
- ↵
- L. Amoasii et al
- ↵
- ↵
- ↵
Log in using your username and password
Log in through your institution
Purchase access
Subscribers, for more details, please visit our Subscriptions FAQ.
Please click here to log into the PNAS submission website.
Citation Manager Formats
Article Classifications
- Biological Sciences
- Cell Biology
See related content: